Loading clinical trials...
Loading clinical trials...
Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)
Conditions
Interventions
Roadsaver™ Carotid Artery Stent Device
Nanoparasol® Embolic Protection System
Locations
37
United States
Abrazo Arizona Heart Hospital
Phoenix, Arizona, United States
St. Luke's Medical Center
Phoenix, Arizona, United States
Yavapai Regional Medical Center
Prescott, Arizona, United States
Kaiser Permanente - Los Angeles
Los Angeles, California, United States
San Diego VA Medical Center
San Diego, California, United States
Radiology Imaging Associates
Denver, Colorado, United States
Start Date
April 21, 2016
Primary Completion Date
April 8, 2022
Completion Date
May 1, 2024
Last Updated
February 28, 2023
NCT07150260
NCT06557135
NCT06936176
NCT06936189
NCT05724836
NCT06541691
Lead Sponsor
Microvention-Terumo, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions